RGNX Past Earnings image   This RGNX past earnings page last updated 5/17/2024
RGNX Past Earnings
PeriodPast Earnings DateGAAP
Q1 20245/8/2024-1.380
Q4 20232/27/2024-1.430
Q3 202311/8/2023-1.410
Q2 20238/2/2023-1.660
Q1 20235/3/2023-1.530
Q4 20222/28/2023-1.380
Q3 202211/3/2022-1.750
Q2 20228/3/2022-1.580
Q1 20225/4/2022-1.580
Q4 20213/1/20226.670
Q3 202111/2/2021-1.370
Q2 20218/9/2021-1.360
Q1 20215/5/2021-1.200
Q4 20203/1/2021-1.240
Q3 202011/4/20200.230
Q2 20208/6/2020-0.910
Q1 20205/7/2020-1.080
Q4 20192/26/2020-0.720
Q3 201911/5/2019-0.940
Q2 20198/7/2019-0.040
Q1 20195/7/2019-0.890
Q4 20182/27/20190.11
Q3 201811/7/2018-0.56
Q2 20188/8/20180.3
Q1 20185/8/20183.04
Q4 20173/6/2018-0.51
Q3 201711/8/2017-0.67
Q2 20178/8/2017-0.47
Q1 20175/9/2017-0.82
Q4 20163/7/2017-0.74
Q3 201611/9/2016-0.69
Q2 20168/9/2016-0.55
Q1 20165/5/2016-0.41
Q4 20153/3/2016-0.2
Q3 201511/5/2015-0.73
RGNX Past Revenue
PeriodPast Earnings DateGAAP
Q1 20245/8/20240.02B
Q4 20232/27/20240.02B
Q3 202311/8/20230.03B
Q2 20238/2/20230.02B
Q1 20235/3/20230.02B
Q4 20222/28/20230.03B
Q3 202211/3/20220.03B
Q2 20228/3/20220.03B
Q1 20225/4/20220.02B
Q4 20213/1/20220.40B
Q3 202111/2/20210.03B
Q2 20218/9/20210.02B
Q1 20215/5/20210.02B
Q4 20203/1/20210.02B
Q3 202011/4/20200.10B
Q2 20208/6/20200.02B
Q1 20205/7/20200.02B
Q4 20192/26/20200.01B
Q3 201911/5/20190.01B
Q2 20198/7/20190.01B
Q1 20195/7/20190.00B
Q4 20182/27/201940.78M
Q3 201811/7/20185.31M
Q2 20188/8/201840.03M
Q1 20185/8/2018132.39M
Q4 20173/6/20182.04M
Q3 201711/8/20171.34M
Q2 20178/8/20176.56M
Q1 20175/9/2017455000
Q4 20163/7/20171.70M
Q3 201611/9/2016125000
Q2 20168/9/20162.38M
Q1 20165/5/2016393000
Q4 20153/3/20164.44M
Q3 201511/5/2015483000
Quotes delayed 20 minutes

Email EnvelopeFree RGNX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Regenxbio (RGNX) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

RIGL Past Earnings
RLAY Past Earnings
RLMD Past Earnings
RLYB Past Earnings
RMD Past Earnings
RMED Past Earnings
RMTI Past Earnings
RNA Past Earnings
RNAC Past Earnings
RNAZ Past Earnings

RGNX Past Earnings Q&A

What was the best and worst RGNX past earnings results?
For Regenxbio, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest RGNX past earnings result in our data set was 6.670/share posted in Q4 2021, while the lowest was in Q3 2022 when RGNX posted -1.750/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q4 2021 when RGNX reported 0.40B in revenue, while the quarter with the lowest revenue in our data set was Q3 2016 at 125000 of revenue.

  Suggested answer: There are 35 RGNX past earnings results in our data set.

On this page we presented the RGNX past earnings date information for Regenxbio. Reviewing that RGNX Past Earnings for the company, we see that the highest past earnings result in our data set was in Q4 2021, when RGNX posted gaap of 6.670/share. Meanwhile the lowest RGNX past earnings result was in Q3 2022, when RGNX posted gaap of -1.750/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q4 2021 when RGNX reported 0.40B in revenue, while the smallest revenue quarter was Q3 2016 when RGNX reported 125000 in revenue.

Any self directed investor doing their due diligence on RGNX or any other given stock can benefit from researching all of the Regenxbio past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Regenxbio past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for RGNX. Thanks for visiting, and the next time you need to research RGNX past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: Top Ten Hedge Funds Holding HSPO, Funds Holding ARKQ, Institutional Holders of MFLX.


RGNX Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.